Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels-Reference-Cited by-同舟云学术

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels

Published:2020-05-21 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Ortner Marion,Stange Marion,Schneider Heike,Schroeder Charlotte,Buerger Katharina,Müller Claudia,Dorn Bianca,Goldhardt Oliver,Diehl-Schmid Janine,Förstl Hans,Steimer Werner,Grimmer Timo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference61 articles.

1. Rivastigmine for Alzheimer's disease;Birks;Cochrane Database Syst. Rev.,2015

2. Cholinesterase inhibitors for Alzheimer's disease;Birks,2006

3. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease;Blesa;Pharmacogenet. Genomics,2006

4. Impact of anticholinergics on the aging brain: a review and practical application;Boustani;Aging Health,2008

5. Factors affecting therapeutic response to Rivastigmine in Alzheimer's disease patients in Taiwan;Chen;Kaohsiung J. Med. Sci.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases;Ageing Research Reviews;2023-02

2. Dose-Related Reference Range as a Tool in Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2022-08

3. Phytochemical Analysis, In Vitro Anticholinesterase, Antioxidant Activity and In Vivo Nootropic Effect of Ferula ammoniacum (Dorema ammoniacum) D. Don. in Scopolamine-Induced Memory Impairment in Mice;Brain Sciences;2021-02-19

4. Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life;Frontiers in Pharmacology;2021-01-29

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil

;Drug Design, Development and Therapy;2020-08